These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36083990)

  • 1. Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study.
    Goto R; Muraki Y; Inose R; Kusama Y; Ono A; Koizumi R; Ishikane M; Ohmagari N
    PLoS One; 2022; 17(9):e0274324. PubMed ID: 36083990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in Japan.
    Fujimori T; Hagiya H; Iio K; Higashionna T; Kakehi A; Okura M; Minabe H; Yokoyama Y; Otsuka F; Higashikage A
    J Infect Chemother; 2022 Jul; 28(7):918-922. PubMed ID: 35351391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.
    Pan KM; Wu Y; Chen C; Chen ZZ; Xu JA; Cao L; Xu Q; Wu W; Dai PF; Li XY; Lv QZ
    Br J Clin Pharmacol; 2018 Aug; 84(8):1706-1718. PubMed ID: 29607531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis.
    Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y
    J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin-an epidemiological surveillance study using Japanese large health insurance claims database.
    Imai S; Momo K; Kashiwagi H; Miyai T; Sugawara M; Takekuma Y
    J Pharm Health Care Sci; 2020; 6():18. PubMed ID: 32832095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit].
    Imaura M; Kohata Y; Kobayashi K; Takahashi H; Yokoyama H; Akase T; Yamada Y
    Yakugaku Zasshi; 2011 Apr; 131(4):563-70. PubMed ID: 21467796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of an AUC
    Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
    Branch-Elliman W; Ripollone JE; O'Brien WJ; Itani KMF; Schweizer ML; Perencevich E; Strymish J; Gupta K
    PLoS Med; 2017 Jul; 14(7):e1002340. PubMed ID: 28692690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmacist-driven methicillin-resistant
    Willis C; Allen B; Tucker C; Rottman K; Epps K
    Am J Health Syst Pharm; 2017 Nov; 74(21):1765-1773. PubMed ID: 29070498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Evaluation of Pharmacist Interventions in Patients Treated with Anti-methicillin-Resistant Staphylococcus aureus Agents in a Hematological Ward.
    Okada N; Fushitani S; Azuma M; Nakamura S; Nakamura T; Teraoka K; Watanabe H; Abe M; Kawazoe K; Ishizawa K
    Biol Pharm Bull; 2016; 39(2):295-300. PubMed ID: 26830489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty.
    Courtney PM; Melnic CM; Zimmer Z; Anari J; Lee GC
    Clin Orthop Relat Res; 2015 Jul; 473(7):2197-203. PubMed ID: 25421958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA; Culshaw DL; Wong-Beringer A; Bensman J; Lamp KC; Smith WJ; Bauer K; Goff DA; Adamson R; Leuthner K; Virata MD; McKinnell JA; Chaudhry SB; Eskandarian R; Lodise T; Reyes K; Zervos MJ
    Clin Ther; 2016 Jan; 38(1):16-30. PubMed ID: 26585355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients.
    Haruki Y; Hagiya H; Haruki M; Inoue Y; Sugiyama T
    J Infect Chemother; 2020 Oct; 26(10):1026-1032. PubMed ID: 32561128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
    Joseph K; Ramireddy K; Madison G; Turco T; Lui M
    J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of trends and factors associated with therapeutic drug monitoring (TDM) implementation for arbekacin treatment using a large Japanese medical claims database.
    Ito S; Goto R; Inose R; Kusama Y; Ono A; Koizumi R; Ishikane M; Ohmagari N; Muraki Y
    J Infect Chemother; 2022 Sep; 28(9):1266-1272. PubMed ID: 35606308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data].
    Xu G; Chen E; Mao E; Che Z; He J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results.
    Kim B; Hwang S; Heo E; Kim HS; Jung J; Kim ES; Kim HB; Lee K; Park JS; Song J; Lee JH; Chung JY; Song KH; Yoon S
    J Korean Med Sci; 2023 Apr; 38(14):e101. PubMed ID: 37038640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of Methicillin-Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature.
    Carr AL; Daley MJ; Givens Merkel K; Rose DT
    Pharmacotherapy; 2018 Dec; 38(12):1216-1228. PubMed ID: 30300441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
    Ley EJ; Liou DZ; Singer MB; Mirocha J; Srour M; Bukur M; Margulies DR; Salim A
    J Surg Res; 2013 Sep; 184(1):501-6. PubMed ID: 23731689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.